TraceSafe Inc.

Unaudited Condensed Consolidated Interim Financial Statements

For the nine months ended September 30, 2021 and 2020 (Expressed in United States dollars unless otherwise stated)

NOTICE TO READER

Under National Instrument 51-102, if an auditor has not performed a review of the interim financial statements, they must be accompanied by a notice indicating that the financial statements have not been reviewed by an auditor.

The accompanying unaudited condensed interim financial statements have been prepared by management and were not reviewed by the Company's independent auditor.

- 1 -

TraceSafe Inc.

Condensed Consolidated Balance Sheets (Expressed in US Dollars - unaudited)

September 30

September 30

2021

2020

Assets

Current assets

Cash

$

1,557,251

$

394,560

Receivables

1,325,592

1,171,511

Prepaid expenses

90,892

891,756

2,973,735

2,457,827

Fixed assets

34,746

-

Research & Development (Note 5)

-

489,024

Investments

4,070,233

1,182,000

Goodwill

3,650,355

-

$

10,729,069

$

4,128,851

Liabilities

Current liabilities

Payables

$

1,963,925

$

726,919

Accrued expenses

641,910

-

Deferred revenue

354,273

30,000

Accounts receivable factoring (Note 7)

937,226

-

Notes Payable (Note 9)

347,825

-

4,245,159

756,919

Shareholders' equity

Share capital (Note 3)

19,421,094

13,943,068

Warrant and option reserve

1,286,206

3,740,056

Equity attributable to non-controlling interest

3,514,415

-

Contributed surplus

820,690

-

Accumulated other comprehensive earnings

(31,828)

(34,797)

Retained earnings

(18,526,666)

(14,276,395)

6,483,910

3,371,932

$

10,731,206

$

4,128,851

- 2 -

TraceSafe Inc.

Condensed Consolidated Statements of Earnings and Comprehensive Loss (Expressed in US Dollars - unaudited)

July 1 to September 30

January 1 to September 30

2021

2020

2021

2020

Revenue

Product sale

$ 5,385,642

$ 1,085,291

$ 9,075,578

$ 1,601,565

Service income

578,981

-

1,575,529

-

Cost of revenue

5,964,623

1,085,291

10,651,107

-

3,441,996

637,034

7,592,089

959,135

Operating expenses

2,522,627

448,257

3,059,018

642,430

Bad debt expense

1,460

-

6,460

-

Bank charges

8,856

3,188

16,223

6,289

Depreciation

2,206

-

4,646

-

Development

521,692

(281,551)

1,466,730

45,504

General and administration (Note 6)

186,896

93,917

569,138

148,683

Marketing

44,411

-

168,286

-

Personnel, payroll, and consultants

926,426

278,920

2,824,865

199,673

Professional fees (Recovery) (Note 10)

(438,750)

549,302

93,731

1,331,870

Regulatory and transfer agent fees

2,756

7,120

25,830

28,886

Stock-based compensation

127,980

227,347

2,254,266

892,985

1,383,933

878,243

7,430,176

2,689,042

Operating Income (Loss)

1,138,694

(429,986)

(4,371,158)

(2,046,612)

Other items

Other income

-

-

(11,891)

-

Interest (Note 11)

164,575

86,863

408,291

255,426

Tax

(20,980)

-

39,308

-

Foreign exchange

(10,623)

(5,508)

12,069

(2,456)

Net income (Loss)

$1,061,630

$(511,341)

$ (4,763,027)

$ (2,299,582)

Net income (Loss) attributed to parent

1,224,836

(940,397)

(2,053,199)

(2,229,582)

Net income (Loss) attributed to non-

controlling interest

(219,113)

(2,765,735)

-

Total comprehensive income (Loss)

$ 1,061,630

$ (511,341)

$ (4,763,027)

$ (2,229,582)

Earnings (Loss) per share attributed to

owners of the parent. Basic and diluted

$ 0.03

$ (0.02)

$ (0.05)

$ (0.08)

Weighted average number of shares

outstanding. Basic and diluted

44,911,641

33,767,168

42,040,252

28,741,435

- 3 -

TraceSafe Inc.

Condensed Consolidated Statements of Changes in Shareholders' Equity (Expressed in US Dollars - unaudited)

July 1 to September 30

January 1 to September 30

2021

2020

2021

2020

Share Capital

Balance - beginning of period

$ 21,616,364

$ 12,355,667

$16,540,138

$ 11,137,327

Issuance of shares by warrants

-

-

2,750,788

246,454

Issuance of shares by options

-

1,587,401

212,095

1,567,397

Issuance of shares for performance

-

-

2,113,343

665,638

Issuance of shares for service

87,900

-

87,900

-

Repurchase of common shares

-

-

-

-

Balance - end of period

$ 21,704,264

$ 13,943,068

$21,704,264

$ 13,943,068

Retained Earnings

Balance - beginning of period

$ (21,741,314)

$ (13,750,593)

$ (15,916,656)

$ (11,976,813)

Net income (Loss)

1,005,722

(525,802)

(4,818,935)

(2,299,582)

Balance - end of period

(20,735,591)

(14,276,395)

(20,735,591)

(14,276,395)

Adjustment for non-controlling

interest

(6,665,482)

-

(6,665,482)

-

Net retained earnings for owners of

parent company

$ (27,401,074)

$ (14,276,395)

$ (27,401,074)

$ (14,276,395)

Number of Shares Outstanding

Balance - beginning of period

44,716,888

31,287,421

35,765,784

22,238,031

Issuance of shares by warrants

-

-

5,828,850

1,097,213

Issuance of shares by options

-

4,153,850

572,254

10,426,027

Issuance of shares for performance

-

-

2,550,000

1,700,000

Issuance of shares for service

194,753

-

194,753

-

Repurchase of common shares

-

-

-

-

Balance - end of period

44,911,641

35,441,271

44,911,641

35,441,271

- 4 -

TraceSafe Inc.

Condensed Consolidated Statements of Cash Flows (Expressed in US Dollars - unaudited)

July 1 to September 30

January 1 to September 30

2021

2020

2021

2020

Operating activities

Net income (Loss)

$ 1,005,722

$ (525,801)

$ (4,818,965)

$ (2,299,582)

Changes in working capital

Accounts Receivable

1,509,923

(705,541)

518,679

(1,170,315)

Prepaid

80,049

(835,388)

731,988

(868,689)

Depreciation

2,201

-

75,774

-

Accounts Payable

(104,339)

(244,344)

836,110

581,558

A/R Factoring Payable

151,635

-

(530,559)

-

Accrued Liabilities

492,065

-

408,068

-

Loan Payable

-

-

110,000

-

Deferred Revenue

(2,470,555)

30,000

300,355

30,000

Share based compensation

-

892,985

-

892,985

666,701

(1,388,089)

(2,368,551)

(2,834,043)

Financing activities

Common Stock

87,900

2,017,339

5,164,127

3,235,679.00

Stock Options

-

-

(2,151,831)

-

Convertible Debenture

-

-

-

781,229

Notes Payable

146,230

-

347,825

-

234,131

2,017,339

3,360,121

4,016,908

Investing activities

Acquisition of TraceSafe Technology

-

-

-

(300,000)

Fixed Assets

(8,302)

(489,024)

(39,746)

(489,024)

(8,302)

(489,024)

(39,746)

(789,024)

Change in cash

892,531

140,226

951,825

393,841

Cash - beginning of period

664,720

254,334

605,426

719

Cash - end of period

$ 1,557,251

$ 394,560

$ 1,557,251

$ 394,560

- 5 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

TraceSafe Inc. published this content on 09 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 November 2021 12:33:04 UTC.